Jesus Vera Aguilera

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav et al. · The Oncologist · 2019 · 134 citations · Full text

Life Sciences, Immunology, Oncology +17

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Narjust Duma, Sejal Kothadia, Tariq U. Azam et al. · The Oncologist · 2018 · 65 citations · Full text

Medicine, Oncology, Chemotherapy +5

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams et al. · Melanoma Research · 2020 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance)

Jesus Vera Aguilera, Ravi D. Rao, Jacob B. Allred et al. · The Oncologist · 2018 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16